Travis Miller
Allergy · Roseville, CANPI 1316958085
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (56.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Genentech USA, Inc. at 41.6% of the total. Among allergy clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 442 payments — averaging $617.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$114K
- AstraZeneca$106K
- Novartis$25K
- Kaleo, Inc.$6K
- Genentech, Inc.$5K
- Optinose US, Inc.$4K
- plus $13K from 18 others
Across 3 payments — averaging $1491.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Teva Pharmaceuticals USA, Inc.$4K
What the payments were for
- Consulting fees$76,89228%
- Speaking & faculty fees$154,52157%
- Travel & lodging$29,80311%
- Food & beverage$11,5874%
- Education$1960%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 172 | $113,665 |
| AstraZeneca | 128 | $105,764 |
| Novartis | 26 | $25,309 |
| Kaleo, Inc. | 3 | $5,625 |
| Genentech, Inc. | 10 | $5,194 |
| Optinose US, Inc. | 13 | $4,247 |
| GSK | 15 | $3,813 |
| Sanofi | 29 | $3,502 |
| Regeneron Healthcare Solutions, Inc. | 14 | $2,527 |
| Aquestive Therapeutics, Inc. | 3 | $1,902 |
| Alk-abello, Inc | 3 | $340 |
| Sanofi-aventis U.S. LLC | 5 | $310 |
| Kyowa Kirin, Inc. | 3 | $188 |
| Pharming Healthcare, Inc. | 1 | $178 |
| Blueprint Medicines Corporation | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $74 |
| Biocryst US Sales Co., LLC | 1 | $74 |
| CSL Behring | 2 | $51 |
| Aimmune Therapeutics, Inc. | 1 | $30 |
| Teva Pharmaceuticals USA, Inc. | 2 | $28 |
| Electromed, Inc. | 3 | $15 |
| Eyevance Pharmaceuticals LLC | 1 | $14 |
| Covis Pharma GmbH | 1 | $13 |
| Advanced Respiratory, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$272,999 in reported general payments places this provider in the 95th percentile of 117 allergy providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $14,296 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $646 |
| Azelastine Hcl | 11 | $476 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $3,813 | $14,29621 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 117 allergy providers in California.
Other allergy in Roseville
- Sunil PereraRoseville$2K
- Joshua JacobsWalnut Creek$1.5M
- Warner CarrLaguna Niguel$571K
- Bradley ChippsSacramento$571K
- Robert ZeigerSan Diego$162K
- William BergerMission Viejo$76K
- Sandra ChristiansenSan Diego$74K
- Stephen WongHacienda Heights$50K
- Michelle YasharpourBeverly Hills$48K
- Stuart EpsteinBeverly Hills$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.